Texas Instruments (TXN) 10-Q21 Oct 202020 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2020	Oct. 13, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-03761
Entity Registrant Name	TEXAS INSTRUMENTS INCORPORATED
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-0289970
Entity Address, Address Line One	12500 TI Boulevard
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75243
City Area Code	214
Local Phone Number	479-3773
Title of 12(b) Security	Common Stock, par value $1.00
Trading Symbol	TXN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		917,942,130
Entity Central Index Key	0000097476
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue	$ 3,817	$ 3,771	$ 10,385	$ 11,033
Cost of revenue (COR)	1,364	1,325	3,762	3,966
Gross profit	2,453	2,446	6,623	7,067
Research and development (R&D)	386	379	1,142	1,158
Selling, general and administrative (SG&A)	407	399	1,225	1,233
Acquisition charges	51	79	151	238
Restructuring charges	0	0	24	(36)
Operating profit	1,609	1,589	4,081	4,474
Other income (expense), net (OI&E)	27	34	151	122
Interest and debt expense	49	43	142	125
Income before income taxes	1,587	1,580	4,090	4,471
Provision for income taxes	234	155	183	524
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Earnings per common share (EPS):
Basic (in dollars per share)	$ 1.47	$ 1.51	$ 4.22	$ 4.19
Diluted (in dollars per share)	$ 1.45	$ 1.49	$ 4.17	$ 4.12
Average shares outstanding (millions):
Basic (in shares)	917	935	921	937
Diluted (in shares)	929	950	933	953
Diluted EPS:
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Income allocated to RSUs	(6)	(8)	(19)	(25)
Income allocated to common stock for diluted EPS	$ 1,347	$ 1,417	$ 3,888	$ 3,922

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of $3 and ($2); $4 and $1	(7)	5	(8)	0
Recognized within net income, net of tax effect of ($2) and ($3); ($7) and ($10)	7	9	21	30
Prior service credit of defined benefit plans:
Recognized within net income, net of tax effect of $0 and $0; $0 and $0	(1)	0	(1)	0
Other comprehensive income (loss), net of taxes	(1)	14	12	30
Total comprehensive income	$ 1,352	$ 1,439	$ 3,919	$ 3,977

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net actuarial losses of defined benefit plans adjustment, tax effect	$ 3	$ (2)	$ 4	$ 1
Net actuarial losses of defined benefit plans recognized within net income, tax effect	(2)	(3)	(7)	(10)
Prior service credit of defined benefit plans recognized within net income, tax effect	$ 0	$ 0	$ 0	$ 0

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 2,822	$ 2,437
Short-term investments	2,696	2,950
Accounts receivable, net of allowances of ($12) and ($8)	1,392	1,074
Raw materials	192	176
Work in process	959	916
Finished goods	921	909
Inventories	2,072	2,001
Prepaid expenses and other current assets	277	299
Total current assets	9,259	8,761
Property, plant and equipment at cost	5,698	5,740
Accumulated depreciation	(2,508)	(2,437)
Property, plant and equipment	3,190	3,303
Long-term investments	47	300
Goodwill	4,362	4,362
Acquisition-related intangibles	189	340
Deferred tax assets	299	197
Capitalized software licenses	133	69
Overfunded retirement plans	227	218
Other long-term assets	501	468
Total assets	18,207	18,018
Current liabilities:
Current portion of long-term debt	550	500
Accounts payable	411	388
Accrued compensation	656	714
Income taxes payable	44	46
Accrued expenses and other liabilities	524	475
Total current liabilities	2,185	2,123
Long-term debt	6,247	5,303
Underfunded retirement plans	103	93
Deferred tax liabilities	69	78
Other long-term liabilities	1,278	1,514
Total liabilities	9,882	9,111
Stockholders’ equity:
Preferred stock, $25 par value. Authorized – 10,000,000 shares Participating cumulative preferred – None issued	0	0
Common stock, $1 par value. Authorized - 2,400,000,000 shares, Shares issued - 1,740,815,939	1,741	1,741
Paid-in capital	2,257	2,110
Retained earnings	41,305	39,898
Treasury common stock at cost shares: Shares: June 30, 2020 – 825,225,307; December 31, 2019 – 808,784,381	(36,643)	(34,495)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(335)	(347)
Total stockholders’ equity	8,325	8,907
Total liabilities and stockholders’ equity	$ 18,207	$ 18,018

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Allowance for doubtful accounts receivable, current	$ 12	$ 8
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400,000,000	2,400,000,000
Common stock, shares issued (in shares)	1,740,815,939	1,740,815,939
Treasury stock (in shares)	823,174,578	808,784,381

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net income	$ 3,907	$ 3,947
Adjustments to net income:
Depreciation	553	522
Amortization of acquisition-related intangibles	151	238
Amortization of capitalized software	45	40
Stock compensation	182	176
Gains on sales of assets	(3)	(23)
Deferred taxes	(115)	31
Increase (decrease) from changes in:
Accounts receivable	(318)	(135)
Inventories	(71)	177
Prepaid expenses and other current assets	0	285
Accounts payable and accrued expenses	60	(64)
Accrued compensation	(48)	(115)
Income taxes payable	(316)	(200)
Changes in funded status of retirement plans	16	26
Other	(29)	(10)
Cash flows from operating activities	4,014	4,895
Cash flows from investing activities
Capital expenditures	(437)	(684)
Proceeds from asset sales	3	30
Purchases of short-term investments	(3,435)	(1,374)
Proceeds from short-term investments	3,958	2,004
Other	(15)	25
Cash flows from investing activities	74	1
Cash flows from financing activities
Proceeds from issuance of long-term debt	1,498	1,491
Repayment of debt	(500)	(750)
Dividends paid	(2,489)	(2,167)
Stock repurchases	(2,538)	(2,471)
Proceeds from common stock transactions	356	491
Other	(30)	(35)
Cash flows from financing activities	(3,703)	(3,441)
Net change in cash and cash equivalents	385	1,455
Cash and cash equivalents at beginning of period	2,437	2,438
Cash and cash equivalents at end of period	$ 2,822	$ 3,893

Description of business, includ

Description of business, including segment and geographic area information	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Description of business, including segment and geographic area information	Description of business, including segment and geographic area information We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments, which are established along major categories of products as follows: • Analog – consisting of the following product lines: Power and Signal Chain. • Embedded Processing – consisting of the following product lines: Connected Microcontrollers and Processors. During the third quarter, we reorganized the product lines within our Analog segment to simplify our business structure into our Power and Signal Chain product lines. These changes had no effect on either our previously reported consolidated financial statements or on our reportable segment results. We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP ® products, calculators and custom ASIC products. Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided. Segment information For Three Months Ended For Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Revenue: Analog $ 2,865 $ 2,674 $ 7,759 $ 7,726 Embedded Processing 651 724 1,850 2,310 Other 301 373 776 997 Total revenue $ 3,817 $ 3,771 $ 10,385 $ 11,033 Operating profit: Analog $ 1,320 $ 1,231 $ 3,398 $ 3,427 Embedded Processing 187 233 494 747 Other (a) 102 125 189 300 Total operating profit $ 1,609 $ 1,589 $ 4,081 $ 4,474 (a) Includes acquisition charges and restructuring charges/other Geographic area information The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products. For Three Months Ended For Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Revenue: United States $ 440 $ 504 $ 1,179 $ 1,468 Asia (a) 2,555 2,263 6,756 6,512 Europe, Middle East and Africa 578 699 1,648 2,151 Japan 140 198 523 607 Rest of world 104 107 279 295 Total revenue $ 3,817 $ 3,771 $ 10,385 $ 11,033 (a) Revenue from products shipped into China was $2.2 billion and $1.9 billion in the third quarters of 2020 and 2019, respectively, and $5.7 billion and $5.4 billion in the first nine months of 2020 and 2019, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

Basis of presentation and signi

Basis of presentation and significant accounting policies and practices	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and significant accounting policies and practices	Basis of presentation and significant accounting policies and practices Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2019. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2020 and 2019, and the Consolidated Balance Sheet as of September 30, 2020, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2019. The results for the three- and nine-month periods are not necessarily indicative of a full year’s results. Significant accounting policies and practices Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock. Computation and reconciliation of earnings per common share are as follows (shares in millions): For Three Months Ended September 30, 2020 2019 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 1,353 $ 1,425 Income allocated to RSUs (6) (9) Income allocated to common stock $ 1,347 917 $ 1.47 $ 1,416 935 $ 1.51 Dilutive effect of stock compensation plans 12 15 Diluted EPS: Net income $ 1,353 $ 1,425 Income allocated to RSUs (6) (8) Income allocated to common stock $ 1,347 929 $ 1.45 $ 1,417 950 $ 1.49 For Nine Months Ended September 30, 2020 2019 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 3,907 $ 3,947 Income allocated to RSUs (19) (25) Income allocated to common stock $ 3,888 921 $ 4.22 $ 3,922 937 $ 4.19 Dilutive effect of stock compensation plans 12 16 Diluted EPS: Net income $ 3,907 $ 3,947 Income allocated to RSUs (19) (25) Income allocated to common stock $ 3,888 933 $ 4.17 $ 3,922 953 $ 4.12 Potentially dilutive securities representing 3 million and 6 million shares of common stock that were outstanding during the third quarters of 2020 and 2019, respectively, and 4 million and 7 million shares outstanding during the first nine months of 2020 and 2019, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive. Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes. Fair values of financial instruments The fair values of our derivative financial instruments were not material as of September 30, 2020. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of September 30, 2020, the carrying value of long-term debt, including the current portion, was $6.80 billion, and the estimated fair value was $7.73 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs. Changes in accounting standards – adopted standards for current period We adopted the following Accounting Standards Updates (ASU) during the current period, none of which had a material impact on our financial position or results of operations. ASU Description Adopted Date ASU No. 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments January 1, 2020 ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement January 1, 2020 ASU No. 2018-15 Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract January 1, 2020

Income taxes

Income taxes	9 Months Ended
Income taxes	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income taxes	Income taxes Our estimated annual effective tax rate is about 14%, which does not include discrete tax items. This differs from the 21% statutory corporate tax rate due to the effect of U.S. tax benefits. Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Taxes calculated using the estimated annual effective tax rate $ 231 $ 257 $ 561 $ 715 Discrete tax items 3 (102) (378) (191) Provision for income taxes $ 234 $ 155 $ 183 $ 524 Actual effective tax rate 15 % 10 % 4 % 12 % Our provision for income taxes for the first nine months of 2020 includes a $249 million discrete tax benefit in the second quarter for the settlement of a depreciation-related uncertain tax position. Accrued interest of $46 million related to this uncertain tax position was reversed in the second quarter and is included in OI&E.

Valuation of debt and equity in

Valuation of debt and equity investments and certain liabilities	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Valuation of debt and equity investments and certain liabilities	Valuation of debt and equity investments and certain liabilities Investments measured at fair value Available-for-sale debt investments and trading securities are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. We classify certain mutual funds as trading securities. These mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E. Details of our investments are as follows: September 30, 2020 December 31, 2019 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Available-for-sale debt securities: Money market funds $ 911 $ — $ — $ 1,213 $ — $ — Corporate obligations 341 256 — 174 1,216 — U.S. government agency and Treasury securities 1,047 2,440 — 604 1,734 — Trading securities: Mutual funds — — 16 — — 272 Total 2,299 2,696 16 1,991 2,950 272 Other measurement basis: Equity-method investments — — 27 — — 24 Non-marketable equity investments — — 4 — — 4 Cash on hand 523 — — 446 — — Total $ 2,822 $ 2,696 $ 47 $ 2,437 $ 2,950 $ 300 As of September 30, 2020 and December 31, 2019, unrealized gains and losses associated with our available-for-sale investments were not material. We did not recognize any credit losses related to available-for-sale investments for the first nine months of 2020 and 2019. All of our debt securities classified as available for sale as of September 30, 2020, have maturities within one year. Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $510 million and $220 million for the third quarters of 2020 and 2019, respectively, and $3.71 billion and $2.00 billion for the first nine months of 2020 and 2019, respectively. Gross realized gains and losses from these sales were not material. During the first nine months of 2020, we entered into total return swaps to economically hedge the variability of certain deferred compensation obligations to employees. As a result, we received proceeds of $253 million from the sale of investments in mutual funds that were previously being utilized to offset this exposure. Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of September 30, 2020, and December 31, 2019, we had no Level 3 assets or liabilities. The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2020 December 31, 2019 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 911 $ — $ 911 $ 1,213 $ — $ 1,213 Corporate obligations — 597 597 — 1,390 1,390 U.S. government agency and Treasury securities 3,487 — 3,487 2,338 — 2,338 Mutual funds 16 — 16 272 — 272 Total assets $ 4,414 $ 597 $ 5,011 $ 3,823 $ 1,390 $ 5,213 Liabilities: Deferred compensation $ 314 $ — $ 314 $ 298 $ — $ 298 Total liabilities $ 314 $ — $ 314 $ 298 $ — $ 298

Goodwill and acquisition-relate

Goodwill and acquisition-related intangibles	9 Months Ended
Goodwill and acquisition-related intangibles	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and acquisition-related intangibles	Goodwill and acquisition-related intangibles Goodwill was $4.36 billion as of September 30, 2020 and December 31, 2019. There was no impairment of goodwill during the first nine months of 2020 or 2019. The components of acquisition-related intangibles are as follows: September 30, 2020 December 31, 2019 Amortization Period (Years) Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Developed technology 8 – 10 $ 1,895 $ 1,706 $ 189 $ 2,000 $ 1,660 $ 340 Acquisition charges Acquisition charges represent the ongoing amortization of intangible assets resulting from the acquisition of National Semiconductor Corporation. These amounts are included in Other for segment reporting purposes, consistent with how management measures the performance of its segments. Amortization of acquisition-related intangibles was $51 million and $79 million for the third quarters of 2020 and 2019, respectively, and $151 million and $238 million for the first nine months of 2020 and 2019. Fully amortized assets are written off against accumulated amortization.

Postretirement benefit plans

Postretirement benefit plans	9 Months Ended
Postretirement benefit plans	Sep. 30, 2020
Retirement Benefits [Abstract]
Postretirement benefit plans	Postretirement benefit plans Expense related to defined benefit and retiree health care benefit plans is as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2020 2019 2020 2019 2020 2019 Service cost $ 5 $ 4 $ 1 $ 1 $ 9 $ 7 Interest cost 7 9 3 4 9 11 Expected return on plan assets (9) (10) (2) (4) (20) (20) Recognized net actuarial loss 1 3 — — 4 6 Amortization of prior service cost (credit) — — (1) (1) — 1 Net periodic benefit costs 4 6 1 — 2 5 Settlement losses 3 3 — — 1 — Total, including other postretirement losses $ 7 $ 9 $ 1 $ — $ 3 $ 5 U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2020 2019 2020 2019 2020 2019 Service cost $ 14 $ 13 $ 2 $ 2 $ 25 $ 23 Interest cost 24 28 9 11 28 33 Expected return on plan assets (27) (31) (8) (11) (58) (64) Recognized net actuarial loss 5 8 — — 11 21 Amortization of prior service cost (credit) — — (1) (1) — 1 Net periodic benefit costs 16 18 2 1 6 14 Settlement losses 10 9 — — 2 2 Total, including other postretirement losses $ 26 $ 27 $ 2 $ 1 $ 8 $ 16

Debt and lines of credit

Debt and lines of credit	9 Months Ended
Debt and lines of credit	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt and lines of credit	Debt and lines of credit Short-term borrowings We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of September 30, 2020, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $2 billion until March 2024. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable London Interbank Offered Rate (LIBOR). As of September 30, 2020, our credit facility was undrawn, and we had no commercial paper outstanding. Long-term debt In the first quarter of 2020, we issued a principal amount of $750 million of fixed-rate, long-term debt due in 2025. We incurred $4 million of issuance costs. The proceeds of the offering were $749 million, net of the original issuance discount, which were used for general corporate purposes and the repayment of maturing debt. In the second quarter of 2020, we retired $500 million of maturing debt. We also issued a principal amount of $750 million of fixed-rate, long-term debt due in 2030. We incurred $5 million of issuance costs. The proceeds of the offering were $749 million, net of the original issuance discount, which were used for general corporate purposes. Long-term debt outstanding is as follows: September 30, December 31, 2020 2019 Notes due 2020 at 1.75% $ — $ 500 Notes due 2021 at 2.75% 550 550 Notes due 2022 at 1.85% 500 500 Notes due 2023 at 2.25% 500 500 Notes due 2024 at 2.625% 300 300 Notes due 2025 at 1.375% 750 — Notes due 2027 at 2.90% 500 500 Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Total debt 6,850 5,850 Net unamortized discounts, premiums and issuance costs (53) (47) Total debt, including net unamortized discounts, premiums and issuance costs 6,797 5,803 Current portion of long-term debt (550) (500) Long-term debt $ 6,247 $ 5,303 Interest and debt expense was $49 million and $43 million for the third quarters of 2020 and 2019, respectively, and $142 million and $125 million for the first nine months of 2020 and 2019, respectively. This was net of the amortized discounts, premiums and issuance costs. Capitalized interest was not material.

Stockholders' equity

Stockholders' equity	9 Months Ended
Stockholders' equity	Sep. 30, 2020
Equity [Abstract]
Stockholders’ equity	Stockholders’ equity Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2019 $ 1,741 $ 2,110 $ 39,898 $ (34,495) $ (347) 2020 Net income — — 1,174 — — Dividends declared and paid ($0.90 per share) — — (841) — — Common stock issued for stock-based awards — (77) — 223 — Stock repurchases — — — (1,730) — Stock compensation — 63 — — — Other comprehensive income (loss), net of taxes — — — — 19 Dividend equivalents on RSUs — — (4) — — Balance, March 31, 2020 1,741 2,096 40,227 (36,002) (328) Net income — — 1,380 — — Dividends declared and paid ($0.90 per share) — — (823) — — Common stock issued for stock-based awards — 17 — 70 — Stock repurchases — — — (793) — Stock compensation — 69 — — — Other comprehensive income (loss), net of taxes — — — — (6) Dividend equivalents on RSUs — — (4) — — Balance, June 30, 2020 1,741 2,182 40,780 (36,725) (334) Net income — — 1,353 — — Dividends declared and paid ($0.90 per share) — — (825) — — Common stock issued for stock-based awards — 26 — 97 — Stock repurchases — — — (15) — Stock compensation — 50 — — — Other comprehensive income (loss), net of taxes — — — — (1) Dividend equivalents on RSUs — — (3) — — Other — (1) — — — Balance, September 30, 2020 $ 1,741 $ 2,257 $ 41,305 $ (36,643) $ (335) Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2018 $ 1,741 $ 1,950 $ 37,906 $ (32,130) $ (473) 2019 Net income — — 1,217 — — Dividends declared and paid ($0.77 per share) — — (724) — — Common stock issued for stock-based awards — (84) — 235 — Stock repurchases — — — (1,185) — Stock compensation — 61 — — — Other comprehensive income (loss), net of taxes — — — — 8 Dividend equivalents on RSUs — — (4) — — Other — — 1 — — Balance, March 31, 2019 1,741 1,927 38,396 (33,080) (465) Net income — — 1,305 — — Dividends declared and paid ($0.77 per share) — — (722) — — Common stock issued for stock-based awards — 10 — 136 — Stock repurchases — — — (830) — Stock compensation — 67 — — — Other comprehensive income (loss), net of taxes — — — — 8 Dividend equivalents on RSUs — — (4) — — Other — (1) (1) (1) — Balance, June 30, 2019 1,741 2,003 38,974 (33,775) (457) Net income — — 1,425 — — Dividends declared and paid ($0.77 per share) — — (721) — — Common stock issued for stock-based awards — 8 — 186 — Stock repurchases — — — (456) — Stock compensation — 48 — — — Other comprehensive income (loss), net of taxes — — — — 14 Dividend equivalents on RSUs — — (4) — — Other — (1) — — — Balance, September 30, 2019 $ 1,741 $ 2,058 $ 39,674 $ (34,045) $ (443)

Contingencies

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. General We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.

Supplemental financial informat

Supplemental financial information	9 Months Ended
Supplemental financial information	Sep. 30, 2020
Supplemental Financial Information [Abstract]
Supplemental financial information	Supplemental financial information Restructuring charges/other During the first nine months of 2020, we recognized $24 million of restructuring charges for severance and benefit costs associated with our Embedded Processing business. As of September 30, 2020, $1 million of payments have been made. Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the third quarters and first nine months of 2020 and 2019. The table below details where these transactions are recorded in our Consolidated Statements of Income. For Three Months Ended For Nine Months Ended Impact to Related Statement of Income Lines September 30, September 30, 2020 2019 2020 2019 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 9 $ 12 $ 28 $ 40 Decrease to OI&E Tax effect (2) (3) (7) (10) Decrease to provision for income taxes Recognized within net income, net of taxes $ 7 $ 9 $ 21 $ 30 Decrease to net income Prior service credit of defined benefit plans: Amortization of prior service credit (a) $ (1) $ — $ (1) $ — Increase to OI&E Tax effect — — — — Increase to provision for income taxes Recognized within net income, net of taxes $ (1) $ — $ (1) $ — Increase to net income (a) Detailed in Note 6. Stock compensation

Basis of presentation and sig_2

Basis of presentation and significant accounting policies and practices (Policies)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2019. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2020 and 2019, and the Consolidated Balance Sheet as of September 30, 2020, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2019. The results for the three- and nine-month periods are not necessarily indicative of a full year’s results.
Earnings per share (EPS)	Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.
Derivatives and hedging	Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes.
Fair values of financial instruments	Fair values of financial instruments The fair values of our derivative financial instruments were not material as of September 30, 2020. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of September 30, 2020, the carrying value of long-term debt, including the current portion, was $6.80 billion, and the estimated fair value was $7.73 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.
Fair value considerations	Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of September 30, 2020, and December 31, 2019, we had no Level 3 assets or liabilities.
Changes in accounting standards	Changes in accounting standards – adopted standards for current period We adopted the following Accounting Standards Updates (ASU) during the current period, none of which had a material impact on our financial position or results of operations. ASU Description Adopted Date ASU No. 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments January 1, 2020 ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement January 1, 2020 ASU No. 2018-15 Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract January 1, 2020
Debt and equity investments	Investments measured at fair value Available-for-sale debt investments and trading securities are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. We classify certain mutual funds as trading securities. These mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.
Indemnification guarantees and warranty costs/product liabilities	Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

Description of business, incl_2

Description of business, including segment and geographic area information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Schedule of Segment Information	For Three Months Ended For Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Revenue: Analog $ 2,865 $ 2,674 $ 7,759 $ 7,726 Embedded Processing 651 724 1,850 2,310 Other 301 373 776 997 Total revenue $ 3,817 $ 3,771 $ 10,385 $ 11,033 Operating profit: Analog $ 1,320 $ 1,231 $ 3,398 $ 3,427 Embedded Processing 187 233 494 747 Other (a) 102 125 189 300 Total operating profit $ 1,609 $ 1,589 $ 4,081 $ 4,474 (a) Includes acquisition charges and restructuring charges/other
Schedule of Geographic Area Information	Geographic area information The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products. For Three Months Ended For Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Revenue: United States $ 440 $ 504 $ 1,179 $ 1,468 Asia (a) 2,555 2,263 6,756 6,512 Europe, Middle East and Africa 578 699 1,648 2,151 Japan 140 198 523 607 Rest of world 104 107 279 295 Total revenue $ 3,817 $ 3,771 $ 10,385 $ 11,033 (a) Revenue from products shipped into China was $2.2 billion and $1.9 billion in the third quarters of 2020 and 2019, respectively, and $5.7 billion and $5.4 billion in the first nine months of 2020 and 2019, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

Basis of presentation and sig_3

Basis of presentation and significant accounting policies and practices (Tables)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share	Computation and reconciliation of earnings per common share are as follows (shares in millions): For Three Months Ended September 30, 2020 2019 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 1,353 $ 1,425 Income allocated to RSUs (6) (9) Income allocated to common stock $ 1,347 917 $ 1.47 $ 1,416 935 $ 1.51 Dilutive effect of stock compensation plans 12 15 Diluted EPS: Net income $ 1,353 $ 1,425 Income allocated to RSUs (6) (8) Income allocated to common stock $ 1,347 929 $ 1.45 $ 1,417 950 $ 1.49 For Nine Months Ended September 30, 2020 2019 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 3,907 $ 3,947 Income allocated to RSUs (19) (25) Income allocated to common stock $ 3,888 921 $ 4.22 $ 3,922 937 $ 4.19 Dilutive effect of stock compensation plans 12 16 Diluted EPS: Net income $ 3,907 $ 3,947 Income allocated to RSUs (19) (25) Income allocated to common stock $ 3,888 933 $ 4.17 $ 3,922 953 $ 4.12
Accounting Standards Updates	We adopted the following Accounting Standards Updates (ASU) during the current period, none of which had a material impact on our financial position or results of operations. ASU Description Adopted Date ASU No. 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments January 1, 2020 ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement January 1, 2020 ASU No. 2018-15 Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract January 1, 2020

Income taxes (Tables)

Income taxes (Tables)	9 Months Ended
Income taxes (Tables)	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Provision for income taxes	Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Taxes calculated using the estimated annual effective tax rate $ 231 $ 257 $ 561 $ 715 Discrete tax items 3 (102) (378) (191) Provision for income taxes $ 234 $ 155 $ 183 $ 524 Actual effective tax rate 15 % 10 % 4 % 12 %

Valuation of debt and equity _2

Valuation of debt and equity investments and certain liabilities (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Investments	Details of our investments are as follows: September 30, 2020 December 31, 2019 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Available-for-sale debt securities: Money market funds $ 911 $ — $ — $ 1,213 $ — $ — Corporate obligations 341 256 — 174 1,216 — U.S. government agency and Treasury securities 1,047 2,440 — 604 1,734 — Trading securities: Mutual funds — — 16 — — 272 Total 2,299 2,696 16 1,991 2,950 272 Other measurement basis: Equity-method investments — — 27 — — 24 Non-marketable equity investments — — 4 — — 4 Cash on hand 523 — — 446 — — Total $ 2,822 $ 2,696 $ 47 $ 2,437 $ 2,950 $ 300
Assets and Liabilities Accounted for at Fair Value	The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2020 December 31, 2019 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 911 $ — $ 911 $ 1,213 $ — $ 1,213 Corporate obligations — 597 597 — 1,390 1,390 U.S. government agency and Treasury securities 3,487 — 3,487 2,338 — 2,338 Mutual funds 16 — 16 272 — 272 Total assets $ 4,414 $ 597 $ 5,011 $ 3,823 $ 1,390 $ 5,213 Liabilities: Deferred compensation $ 314 $ — $ 314 $ 298 $ — $ 298 Total liabilities $ 314 $ — $ 314 $ 298 $ — $ 298

Goodwill and acquisition-rela_2

Goodwill and acquisition-related intangibles (Tables)	9 Months Ended
Goodwill and acquisition-related intangibles (Tables)	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquisition-Related Intangible Assets	The components of acquisition-related intangibles are as follows: September 30, 2020 December 31, 2019 Amortization Period (Years) Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Developed technology 8 – 10 $ 1,895 $ 1,706 $ 189 $ 2,000 $ 1,660 $ 340

Postretirement benefit plans (T

Postretirement benefit plans (Tables)	9 Months Ended
Postretirement benefit plans (Tables)	Sep. 30, 2020
Retirement Benefits [Abstract]
Expense Related to Defined Benefit and Retiree Health Care Benefit Plans	Expense related to defined benefit and retiree health care benefit plans is as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2020 2019 2020 2019 2020 2019 Service cost $ 5 $ 4 $ 1 $ 1 $ 9 $ 7 Interest cost 7 9 3 4 9 11 Expected return on plan assets (9) (10) (2) (4) (20) (20) Recognized net actuarial loss 1 3 — — 4 6 Amortization of prior service cost (credit) — — (1) (1) — 1 Net periodic benefit costs 4 6 1 — 2 5 Settlement losses 3 3 — — 1 — Total, including other postretirement losses $ 7 $ 9 $ 1 $ — $ 3 $ 5 U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2020 2019 2020 2019 2020 2019 Service cost $ 14 $ 13 $ 2 $ 2 $ 25 $ 23 Interest cost 24 28 9 11 28 33 Expected return on plan assets (27) (31) (8) (11) (58) (64) Recognized net actuarial loss 5 8 — — 11 21 Amortization of prior service cost (credit) — — (1) (1) — 1 Net periodic benefit costs 16 18 2 1 6 14 Settlement losses 10 9 — — 2 2 Total, including other postretirement losses $ 26 $ 27 $ 2 $ 1 $ 8 $ 16

Debt and lines of credit (Table

Debt and lines of credit (Tables)	9 Months Ended
Debt and lines of credit (Tables)	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt outstanding is as follows: September 30, December 31, 2020 2019 Notes due 2020 at 1.75% $ — $ 500 Notes due 2021 at 2.75% 550 550 Notes due 2022 at 1.85% 500 500 Notes due 2023 at 2.25% 500 500 Notes due 2024 at 2.625% 300 300 Notes due 2025 at 1.375% 750 — Notes due 2027 at 2.90% 500 500 Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Total debt 6,850 5,850 Net unamortized discounts, premiums and issuance costs (53) (47) Total debt, including net unamortized discounts, premiums and issuance costs 6,797 5,803 Current portion of long-term debt (550) (500) Long-term debt $ 6,247 $ 5,303

Stockholders' equity (Tables)

Stockholders' equity (Tables)	9 Months Ended
Stockholders' equity (Tables)	Sep. 30, 2020
Equity [Abstract]
Schedule of Changes in Stockholders' Equity	Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2019 $ 1,741 $ 2,110 $ 39,898 $ (34,495) $ (347) 2020 Net income — — 1,174 — — Dividends declared and paid ($0.90 per share) — — (841) — — Common stock issued for stock-based awards — (77) — 223 — Stock repurchases — — — (1,730) — Stock compensation — 63 — — — Other comprehensive income (loss), net of taxes — — — — 19 Dividend equivalents on RSUs — — (4) — — Balance, March 31, 2020 1,741 2,096 40,227 (36,002) (328) Net income — — 1,380 — — Dividends declared and paid ($0.90 per share) — — (823) — — Common stock issued for stock-based awards — 17 — 70 — Stock repurchases — — — (793) — Stock compensation — 69 — — — Other comprehensive income (loss), net of taxes — — — — (6) Dividend equivalents on RSUs — — (4) — — Balance, June 30, 2020 1,741 2,182 40,780 (36,725) (334) Net income — — 1,353 — — Dividends declared and paid ($0.90 per share) — — (825) — — Common stock issued for stock-based awards — 26 — 97 — Stock repurchases — — — (15) — Stock compensation — 50 — — — Other comprehensive income (loss), net of taxes — — — — (1) Dividend equivalents on RSUs — — (3) — — Other — (1) — — — Balance, September 30, 2020 $ 1,741 $ 2,257 $ 41,305 $ (36,643) $ (335) Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2018 $ 1,741 $ 1,950 $ 37,906 $ (32,130) $ (473) 2019 Net income — — 1,217 — — Dividends declared and paid ($0.77 per share) — — (724) — — Common stock issued for stock-based awards — (84) — 235 — Stock repurchases — — — (1,185) — Stock compensation — 61 — — — Other comprehensive income (loss), net of taxes — — — — 8 Dividend equivalents on RSUs — — (4) — — Other — — 1 — — Balance, March 31, 2019 1,741 1,927 38,396 (33,080) (465) Net income — — 1,305 — — Dividends declared and paid ($0.77 per share) — — (722) — — Common stock issued for stock-based awards — 10 — 136 — Stock repurchases — — — (830) — Stock compensation — 67 — — — Other comprehensive income (loss), net of taxes — — — — 8 Dividend equivalents on RSUs — — (4) — — Other — (1) (1) (1) — Balance, June 30, 2019 1,741 2,003 38,974 (33,775) (457) Net income — — 1,425 — — Dividends declared and paid ($0.77 per share) — — (721) — — Common stock issued for stock-based awards — 8 — 186 — Stock repurchases — — — (456) — Stock compensation — 48 — — — Other comprehensive income (loss), net of taxes — — — — 14 Dividend equivalents on RSUs — — (4) — — Other — (1) — — — Balance, September 30, 2019 $ 1,741 $ 2,058 $ 39,674 $ (34,045) $ (443)

Supplemental financial inform_2

Supplemental financial information (Tables)	9 Months Ended
Supplemental financial information (Tables)	Sep. 30, 2020
Supplemental Financial Information [Abstract]
Amounts Reclassified Out of AOCI to Net Income, Net of Taxes	The table below details where these transactions are recorded in our Consolidated Statements of Income. For Three Months Ended For Nine Months Ended Impact to Related Statement of Income Lines September 30, September 30, 2020 2019 2020 2019 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 9 $ 12 $ 28 $ 40 Decrease to OI&E Tax effect (2) (3) (7) (10) Decrease to provision for income taxes Recognized within net income, net of taxes $ 7 $ 9 $ 21 $ 30 Decrease to net income Prior service credit of defined benefit plans: Amortization of prior service credit (a) $ (1) $ — $ (1) $ — Increase to OI&E Tax effect — — — — Increase to provision for income taxes Recognized within net income, net of taxes $ (1) $ — $ (1) $ — Increase to net income (a) Detailed in Note 6.

Description of business, incl_3

Description of business, including segment and geographic area information - Additional Information (Details)	9 Months Ended
	Sep. 30, 2020reportable_segment
Segment Reporting [Abstract]
Number of reportable segments	2

Description of business, incl_4

Description of business, including segment and geographic area information - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Total revenue	$ 3,817	$ 3,771	$ 10,385	$ 11,033
Total operating profit	1,609	1,589	4,081	4,474
Analog
Segment Reporting Information [Line Items]
Total revenue	2,865	2,674	7,759	7,726
Total operating profit	1,320	1,231	3,398	3,427
Embedded Processing
Segment Reporting Information [Line Items]
Total revenue	651	724	1,850	2,310
Total operating profit	187	233	494	747
Other
Segment Reporting Information [Line Items]
Total revenue	301	373	776	997
Total operating profit	$ 102	$ 125	$ 189	$ 300

Description of business, incl_5

Description of business, including segment and geographic area information - Geographic Area Information (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Total revenue		$ 3,817	$ 3,771	$ 10,385	$ 11,033
United States
Segment Reporting Information [Line Items]
Total revenue		440	504	1,179	1,468
Asia
Segment Reporting Information [Line Items]
Total revenue	[1]	2,555	2,263	6,756	6,512
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Total revenue		578	699	1,648	2,151
Japan
Segment Reporting Information [Line Items]
Total revenue		140	198	523	607
Rest of world
Segment Reporting Information [Line Items]
Total revenue		104	107	279	295
China
Segment Reporting Information [Line Items]
Total revenue		$ 2,200	$ 1,900	$ 5,700	$ 5,400

[1]	Revenue from products shipped into China was $2.2 billion and $1.9 billion in the third quarters of 2020 and 2019, respectively, and $5.7 billion and $5.4 billion in the first nine months of 2020 and 2019, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

Basis of presentation and sig_4

Basis of presentation and significant accounting policies and practices - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Basic EPS:
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Income allocated to RSUs	(6)	(9)	(19)	(25)
Income allocated to common stock for basic EPS	$ 1,347	$ 1,416	$ 3,888	$ 3,922
Weighted average number of shares outstanding, basic (in shares)	917	935	921	937
Basic (in dollars per share)	$ 1.47	$ 1.51	$ 4.22	$ 4.19
Dilutive effect of stock compensation plans (in shares)	12	15	12	16
Diluted EPS:
Net income	$ 1,353	$ 1,425	$ 3,907	$ 3,947
Income allocated to RSUs	(6)	(8)	(19)	(25)
Income allocated to common stock for diluted EPS	$ 1,347	$ 1,417	$ 3,888	$ 3,922
Weighted average number of shares outstanding, diluted (in shares)	929	950	933	953
Diluted (in dollars per share)	$ 1.45	$ 1.49	$ 4.17	$ 4.12

Basis of presentation and sig_5

Basis of presentation and significant accounting policies and practices - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Antidilutive securities excluded from computation of earnings per share, Amount (in shares)	3	6	4	7
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, carrying value	$ 6,797		$ 6,797		$ 5,803
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, estimated fair value	$ 7,730		$ 7,730

Income taxes - Additional Infor

Income taxes - Additional Information (Details) $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)
Income Tax Disclosure [Abstract]
Estimated annual effective tax rate	14.00%
Statutory corporate tax rate	21.00%
Amount of tax benefit for tax settlements	$ 249
Accrued interest related to uncertain tax position	$ 46

Income taxes - Provision for In

Income taxes - Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Taxes calculated using the estimated annual effective tax rate	$ 231	$ 257	$ 561	$ 715
Discrete tax items	3	(102)	(378)	(191)
Provision for income taxes	$ 234	$ 155	$ 183	$ 524
Actual effective tax rate	15.00%	10.00%	4.00%	12.00%

Valuation of debt and equity _3

Valuation of debt and equity investments and certain liabilities - Investments at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	$ 2,822	$ 2,437
Short-Term Investments	2,696	2,950
Long-Term Investments	47	300
Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	2,299	1,991
Short-Term Investments	2,696	2,950
Long-Term Investments	16	272
Measured at fair value \| Available-for-sale debt securities \| Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	911	1,213
Short-Term Investments	0	0
Long-Term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| Corporate obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	341	174
Short-Term Investments	256	1,216
Long-Term Investments	0	0
Measured at fair value \| Available-for-sale debt securities \| U.S. government agency and Treasury securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,047	604
Short-Term Investments	2,440	1,734
Long-Term Investments	0	0
Measured at fair value \| Trading securities \| Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	16	272
Other measurement basis \| Equity-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	27	24
Other measurement basis \| Non-marketable equity investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	4	4
Other measurement basis \| Cash on hand
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	523	446
Short-Term Investments	0	0
Long-Term Investments	$ 0	$ 0

Valuation of debt and equity _4

Valuation of debt and equity investments and certain liabilities - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Credit losses related to available-for-sale investments			$ 0
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments	$ 510,000,000	$ 220,000,000	3,710,000,000	$ 2,000,000,000
Proceeds from sale of short-term investments			253,000,000
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities, fair value	0		0
Assets, fair value	$ 0		$ 0

Valuation of debt and equity _5

Valuation of debt and equity investments and certain liabilities - Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Recurring - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 5,011	$ 5,213
Total liabilities fair value	314	298
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	314	298
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	4,414	3,823
Total liabilities fair value	314	298
Level 1 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	314	298
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	597	1,390
Total liabilities fair value	0	0
Level 2 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	911	1,213
Money market funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	911	1,213
Money market funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	597	1,390
Corporate obligations \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	597	1,390
U.S. government agency and Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,487	2,338
U.S. government agency and Treasury securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,487	2,338
U.S. government agency and Treasury securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	16	272
Mutual funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	16	272
Mutual funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 0	$ 0

Goodwill and acquisition-rela_3

Goodwill and acquisition-related intangibles - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,362,000,000		$ 4,362,000,000		$ 4,362,000,000
Goodwill impairment loss			0	$ 0
Amortization of acquisition-related intangibles	$ 51,000,000	$ 79,000,000	$ 151,000,000	$ 238,000,000

Goodwill and acquisition-rela_4

Goodwill and acquisition-related intangibles - Components of Acquisition Related Intangible Assets (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition-related intangibles, net	$ 189	$ 340
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition-related intangibles, gross carrying amount	1,895	2,000
Acquisition-related intangibles, accumulated amortization	1,706	1,660
Acquisition-related intangibles, net	$ 189	$ 340
Developed technology \| Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition-related intangibles, amortization period	8 years
Developed technology \| Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Acquisition-related intangibles, amortization period	10 years

Postretirement benefit plans -

Postretirement benefit plans - Expense Related to Defined Benefit and Retiree Health Care Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
U.S. \| Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 5	$ 4	$ 14	$ 13
Interest cost	7	9	24	28
Expected return on plan assets	(9)	(10)	(27)	(31)
Recognized net actuarial loss	1	3	5	8
Amortization of prior service cost (credit)	0	0	0	0
Net periodic benefit costs	4	6	16	18
Settlement losses	3	3	10	9
Total, including other postretirement losses	7	9	26	27
U.S. \| Retiree health care plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	1	2	2
Interest cost	3	4	9	11
Expected return on plan assets	(2)	(4)	(8)	(11)
Recognized net actuarial loss	0	0	0	0
Amortization of prior service cost (credit)	(1)	(1)	(1)	(1)
Net periodic benefit costs	1	0	2	1
Settlement losses	0	0	0	0
Total, including other postretirement losses	1	0	2	1
Non-U.S. \| Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	9	7	25	23
Interest cost	9	11	28	33
Expected return on plan assets	(20)	(20)	(58)	(64)
Recognized net actuarial loss	4	6	11	21
Amortization of prior service cost (credit)	0	1	0	1
Net periodic benefit costs	2	5	6	14
Settlement losses	1	0	2	2
Total, including other postretirement losses	$ 3	$ 5	$ 8	$ 16

Debt and lines of credit - Addi

Debt and lines of credit - Additional Information (Details) - USD ($)	3 Months Ended				9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Commercial paper	$ 0				$ 0
Proceeds from issuance of long-term debt					1,498,000,000	$ 1,491,000,000
Interest and debt expense	$ 49,000,000			$ 43,000,000	$ 142,000,000	$ 125,000,000
Notes due 2020 at 1.75%
Debt Instrument [Line Items]
Retirement of debt		$ 500,000,000
Long-term debt stated interest rate (in percentage)	1.75%				1.75%
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Principal amount			$ 750,000,000
Payments of debt issuance costs			4,000,000
Proceeds from issuance of long-term debt			$ 749,000,000
Long-term debt stated interest rate (in percentage)	1.375%				1.375%
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Principal amount		750,000,000
Payments of debt issuance costs		5,000,000
Proceeds from issuance of long-term debt		$ 749,000,000
Long-term debt stated interest rate (in percentage)	1.75%				1.75%
Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 2,000,000,000				$ 2,000,000,000

Debt and lines of credit - Sche

Debt and lines of credit - Schedule of Long-term Debt Outstanding (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total debt	$ 6,850	$ 5,850
Net unamortized discounts, premiums and issuance costs	(53)	(47)
Total debt, including net unamortized discounts, premiums and issuance costs	6,797	5,803
Current portion of long-term debt	(550)	(500)
Long-term debt	$ 6,247	5,303
Notes due 2020 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 0	500
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.75%
Total debt	$ 550	550
Notes due 2022 at 1.85%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.85%
Total debt	$ 500	500
Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 500	500
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.625%
Total debt	$ 300	300
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.375%
Total debt	$ 750	0
Notes due 2027 at 2.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.90%
Total debt	$ 500	500
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 750	750
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 750	0
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.875%
Total debt	$ 750	750
Notes due 2048 at 4.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.15%
Total debt	$ 1,500	$ 1,500

Stockholders' equity - Schedule

Stockholders' equity - Schedule of Changes in Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning			$ 8,907				$ 8,907
Net income	$ 1,353			$ 1,425			3,907	$ 3,947
Other comprehensive income (loss), net of taxes	(1)			14			12	30
Balance, ending	8,325						8,325
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	1,741	$ 1,741	1,741	1,741	$ 1,741	$ 1,741	1,741	1,741
Net income	0	0	0	0	0	0
Dividends declared and paid	0	0	0	0	0	0
Common stock issued for stock-based awards	0	0	0	0	0	0
Stock repurchases	0	0	0	0	0	0
Stock compensation	0	0	0	0	0	0
Other comprehensive income (loss), net of taxes	0	0	0	0	0	0
Dividend equivalents on RSUs	0	0	0	0	0	0
Other	0			0	0	0
Balance, ending	1,741	1,741	1,741	1,741	1,741	1,741	1,741	1,741
Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	2,182	2,096	2,110	2,003	1,927	1,950	2,110	1,950
Net income	0	0	0	0	0	0
Dividends declared and paid	0	0	0	0	0	0
Common stock issued for stock-based awards	26	17	(77)	8	10	(84)
Stock repurchases	0	0	0	0	0	0
Stock compensation	50	69	63	48	67	61
Other comprehensive income (loss), net of taxes	0	0	0	0	0	0
Dividend equivalents on RSUs	0	0	0	0	0	0
Other	(1)			(1)	(1)	0
Balance, ending	2,257	2,182	2,096	2,058	2,003	1,927	2,257	2,058
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	40,780	40,227	39,898	38,974	38,396	37,906	39,898	37,906
Net income	1,353	1,380	1,174	1,425	1,305	1,217
Dividends declared and paid	(825)	(823)	(841)	(721)	(722)	(724)
Common stock issued for stock-based awards	0	0	0	0	0	0
Stock repurchases	0	0	0	0	0	0
Stock compensation	0	0	0	0	0	0
Other comprehensive income (loss), net of taxes	0	0	0	0	0	0
Dividend equivalents on RSUs	(3)	(4)	(4)	(4)	(4)	(4)
Other	0			0	(1)	1
Balance, ending	41,305	40,780	40,227	39,674	38,974	38,396	41,305	39,674
Treasury Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(36,725)	(36,002)	(34,495)	(33,775)	(33,080)	(32,130)	(34,495)	(32,130)
Net income	0	0	0	0	0	0
Dividends declared and paid	0	0	0	0	0	0
Common stock issued for stock-based awards	97	70	223	186	136	235
Stock repurchases	(15)	(793)	(1,730)	(456)	(830)	(1,185)
Stock compensation	0	0	0	0	0	0
Other comprehensive income (loss), net of taxes	0	0	0	0	0	0
Dividend equivalents on RSUs	0	0	0	0	0	0
Other	0			0	(1)	0
Balance, ending	(36,643)	(36,725)	(36,002)	(34,045)	(33,775)	(33,080)	(36,643)	(34,045)
AOCI
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(334)	(328)	(347)	(457)	(465)	(473)	(347)	(473)
Net income	0	0	0	0	0	0
Dividends declared and paid	0	0	0	0	0	0
Common stock issued for stock-based awards	0	0	0	0	0	0
Stock repurchases	0	0	0	0	0	0
Stock compensation	0	0	0	0	0	0
Other comprehensive income (loss), net of taxes	(1)	(6)	19	14	8	8
Dividend equivalents on RSUs	0	0	0	0	0	0
Other	0			0	0	0
Balance, ending	$ (335)	$ (334)	$ (328)	$ (443)	$ (457)	$ (465)	$ (335)	$ (443)

Stockholders' equity - Addition

Stockholders' equity - Additional Information (Details) - $ / shares	3 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019
Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 0.90	$ 0.90	$ 0.90	$ 0.77	$ 0.77	$ 0.77
Cash dividends paid per common share (in dollars per share)	$ 0.90	$ 0.90	$ 0.90	$ 0.77	$ 0.77	$ 0.77

Supplemental financial inform_3

Supplemental financial information - Amounts Reclassified out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)		$ 27	$ 34	$ 151	$ 122
Provision for income taxes		(234)	(155)	(183)	(524)
Net income		1,353	1,425	3,907	3,947
Reclassification out of Accumulated Other Comprehensive Income \| Net actuarial losses of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	9	12	28	40
Provision for income taxes		(2)	(3)	(7)	(10)
Net income		7	9	21	30
Reclassification out of Accumulated Other Comprehensive Income \| Prior service credit of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	(1)	0	(1)	0
Provision for income taxes		0	0	0	0
Net income		$ (1)	$ 0	$ (1)	$ 0

[1]	Detailed in Note 6.

Supplemental financial inform_4

Supplemental financial information - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0	$ 0	$ 24	$ (36)
Treasury shares issued related to stock compensation (in shares)	2,160,645		8,943,825
Severance and benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 24
Restructuring payments			$ 1